Columnists
Tipsheet
Cartoons
Podcasts
Newsletters
Sections
Podcasts
Townhall TV
Election
Capitol Voices
Entertainment
Radio News
Live Blog
Topics
Sites
Hot Air
PJ Media
Bearing Arms
Twitchy
RedState
JOIN VIP
LOGIN
MY ACCOUNT
Account Settings
Newsletter Subscriptions
Log Out
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
490.33
+2.96 (+0.61%)
Streaming Delayed Price
Updated: 10:24 AM EDT, Aug 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Healthcare And Biotech Investing: Breakthroughs In The Treatment Of Cancer At ASCO
June 10, 2024
Healthcare stocks underperformed YTD because of weakness in UNH and strength in Technology and Communication Services.
Via
Talk Markets
Cathie Wood Goes Bargain Hunting: 2 Stocks She Just Bought
June 09, 2024
These companies could generate explosive growth over time.
Via
The Motley Fool
Arcturus' Inhaled mRNA Therapeutic In Cystic Fibrosis Study Highlights Potential Amid Competitive Landscape: Analyst
June 07, 2024
Arcturus Therapeutics shared Phase 1 and Phase 1b trial results for ARCT-032, an inhaled mRNA therapeutic for cystic fibrosis, showing FEV1 improvements and safety .
Via
Benzinga
Vertex Presents New Data at the European Cystic Fibrosis Conference Demonstrating Significant Benefits of Treatment with TRIKAFTA®
June 07, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
$1000 Invested In Vertex Pharmaceuticals 5 Years Ago Would Be Worth This Much Today
June 05, 2024
Via
Benzinga
This Is What Whales Are Betting On Vertex Pharmaceuticals
June 03, 2024
Via
Benzinga
Analyst Expectations For Vertex Pharmaceuticals's Future
May 31, 2024
Via
Benzinga
Large Cap BIopharmaceuticals Overview
June 03, 2024
As a defensive play healthcare is weighted at about 12% of the S&P 500.
Via
Talk Markets
Topics
Stocks
Exposures
US Equities
3 No-Brainer Stocks to Buy in June
June 02, 2024
Now is the time to invest in these great stocks.
Via
The Motley Fool
5 Top Stocks to Buy in June
June 02, 2024
This medley of growth, value, and income stocks is poised to thrive long-term, even if the stock market sells off this summer.
Via
The Motley Fool
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
June 01, 2024
Eli Lilly is in a buy zone, while rival Novo Nordisk forged a lower entry.
Via
Investor's Business Daily
Topics
Stocks
Exposures
US Equities
A Very Bullish Reversal Produces A Huge Batch Of Actionable Stocks
May 31, 2024
It is very hard to get excited about what I'm seeing in the stock market because things have not been the way I've wanted them to be. In this video, I want to show you something as we look at a monthly...
Via
Talk Markets
While growth is established for NASDAQ:VRTX, the stock's valuation remains reasonable.
May 29, 2024
NASDAQ:VRTX is showing decent growth, but is still valued reasonably.
Via
Chartmill
2 Biotech Stocks to Buy in May
May 25, 2024
You could buy these in any month, really.
Via
The Motley Fool
Spotlight on Vertex Pharmaceuticals: Analyzing the Surge in Options Activity
May 23, 2024
Via
Benzinga
Vertex Stock Recently Hit All-Time High, Leads 8 Top Performers New To IBD Stock Lists
May 31, 2024
Vertex stock was one of a select group of eight that made it onto IBD top-stocks lists Friday. The big pharma is near its all-time high.
Via
Investor's Business Daily
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals?
May 30, 2024
Vertex might not present a clear and present danger to Abbott and DexCom but could present a clear future threat.
Via
The Motley Fool
Arcturus Therapeutics' Early Cystic Fibrosis Trial Results Encouraging - Analyst Cautiously Optimistic
May 28, 2024
Arcturus Therapeutics' early Phase 1 results show ARCT-032 is safe and well-tolerated, with promising improvements in lung function.
Via
Benzinga
Got $500? 3 Pharma Stocks to Buy and Hold Forever
May 26, 2024
These players might even beat the market when the conditions are right.
Via
The Motley Fool
Is It Too Late to Buy Vertex Pharmaceuticals Stock?
May 26, 2024
Shares of the growing biotech company have doubled in three years.
Via
The Motley Fool
3 High-Flying Stocks That Could Soar Even More
May 25, 2024
The momentum should continue for Eli Lilly, Novo Nordisk, and Vertex Pharmaceuticals.
Via
The Motley Fool
Should you consider NASDAQ:VRTX for quality investing?
May 22, 2024
VERTEX PHARMACEUTICALS INC (NASDAQ:VRTX) Exhibits Quality Stock Traits. Here's Why.
Via
Chartmill
Vertex Pharmaceuticals's Options Frenzy: What You Need to Know
May 15, 2024
Via
Benzinga
SLB, First Solar And 2 Other Stocks Insiders Are Selling
May 23, 2024
Via
Benzinga
Walmart, Vertex Pharmaceuticals And More On CNBC's 'Final Trades'
May 23, 2024
Walmart Inc. reported a "really strong" quarter, with e-commerce sales surging 21%. Adjusted EPS was 60 cents.
Via
Benzinga
The 2030 Millionaire’s Club: 3 Biotech Stocks to Buy Now
May 23, 2024
With interest cuts on the horizon, it's a prime time to consider these high-risk-high-reward biotech stocks to buy.
Via
InvestorPlace
Vertex to Participate in Upcoming June Investor Conferences
May 22, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
Halozyme Therapeutics Stock Earns IBD Stock Rating Upgrade, Hitting 80-Plus RS Rating
May 16, 2024
On Thursday, biotech Halozyme Therapeutics stock had its Relative Strength (RS) Rating upgraded to 84, up from 80 a day earlier.
Via
Investor's Business Daily
Is CRISPR Stock Going to $95? 1 Wall Street Analyst Thinks So.
May 15, 2024
How much would you pay for a stock that might earn $25 a year in six years?
Via
The Motley Fool
Jennifer Schneider Elected to Vertex Board of Directors
May 15, 2024
From
Vertex Pharmaceuticals Incorporated
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.